Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 28, 2015 1:14 PM ET

Health Care Technology

Company Overview of Schrödinger, LLC

Company Overview

Schrödinger, LLC develops chemical simulation software for use in pharmaceutical and biotechnology research. The company provides products ranging from general molecular modeling programs to a suite of drug design software, including ligand- and structure-based methods. It also provides products in various research areas, including small molecule modeling and simulations, macromolecular modeling and simulations, lead discovery, lead optimization, and visualization and automation. The company’s software allows scientists to accelerate their research and development activities, as well as to make novel discoveries. It serves pharmaceutical and biotech companies, universities, non-profit instit...

101 S.W. Main Street

Suite 1300

Portland, OR 97204

United States

Founded in 1990





Key Executives for Schrödinger, LLC

Co-Founder, Chief Operating Officer and Chief Financial Officer
Vice President and General Counsel
Managing Director and Senior Vice President
Senior Vice President of Strategy and Member of the Scientific Advisory Board
Compensation as of Fiscal Year 2014.

Schrödinger, LLC Key Developments

Schrodinger Signs Drug Discovery Collaboration with Sanofi

Schrodinger signed a multi-year early drug discovery collaboration with Sanofi. Under the contract, Schrodinger will offer target analysis and validation to lead identification and lead optimisation for around ten drug discovery programmes. Schrodinger is to receive up to USD 120 million, which includes preclinical milestones. A new enterprise informatics system will also facilitate real-time collaboration between computational designers and medicinal chemists and will serve as the communications and project management platform for researchers across both firms.

Sanofi Signs $120 million Collaboration Agreement with Schrodinger

Sanofi announced it has entered into a collaboration agreement with Schrodinger. Under the agreement, Schrodinger will provide comprehensive computational drug design support for as many as ten drug discovery programs. In return, Sanofi will pay up to $120 million, including pre-clinical milestones.

Schrödinger Inc. and Professor Mark E. Thompson Announce Research Collaboration to Enable Computer-Aided Design of Organic Semiconductor Materials

Schrödinger Inc. and Dr. Mark E. Thompson, Professor of Chemistry at the University of Southern California, announced their joint research collaboration to advance the development and design of organic semiconductor materials through use of atomic-scale simulations. Organic semiconductors are a class of materials that have a wide range of electronic device applications, including organic solar cells and detectors, organic light-emitting diodes (OLEDs), and thin-film transistors. Evaluating expansive chemical space to identify good synthetic targets for organic semiconductors is a challenge that limits the rate of new organic materials development. Schrödinger has previously developed software tools for the discovery of new drug candidates through a method known as virtual screening, which involves the use of high-throughput simulation techniques to predict the candidate systems' chemical properties followed by ranking to identify the most promising lead systems. One of the focuses of this collaboration is to leverage these virtual screening methods for the discovery of novel organic semiconductor materials. Schrödinger's Materials Science Suite 1.0 is available now and provides atomic-scale simulation capabilities for chemical systems used in a wide range of technological applications, including optoelectronics, functional additives, engineered catalysts, and reactive precursors.

Similar Private Companies By Industry

Company Name Region
Sway Medical, LLC United States
Information Control LLC United States
Sprigley United States
InteGreat, LLC United States
CT Technologies Holdings, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Schrödinger, LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at